medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2018, Number 2

<< Back Next >>

An Med Asoc Med Hosp ABC 2018; 63 (2)

Metastasic infection associated with bacteremia by Staphylococcus aureus methicillin-sensitive

Montiel RS, Galnares OJA, Palpacelli BMR, Jauregui CL

Language: Spanish
References: 17
Page: 142-145
PDF size: 184.05 Kb.


ABSTRACT

Staphylococcus aureus is a ubiquitous bacterium that, due to its taxonomic characteristics, is classified as a Gram-positive, facultative, aerobic coccus, which has the microscopic characteristic of growing in the form of clusters. Staphylococcus aureus infection can occur at the level of different organs ranging from skin, bone, joints, respiratory system, etc. In this case report we present the case of a 72-year-old female patient who was treated with corticosteroids by pontine myelinolysis, who was diagnosed with meticillin-sensitive Staphylococcus aureus pneumonia after her discharge, with remission after treatment with cefepime and clindamycin. Subsequently she presented with cellulitis and septic arthritis secondary to bacteremia due to Staphylococcus aureus methicillin-sensitive, with definitive treatment based on Daptomycin, with remission of infection. The objective is to conduct a review for bacteremia due to Staphylococcus aureus approach and treatment.


REFERENCES

  2. Stefani S, Goglio A. Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance. Int J Infect Dis. 2010; 14 Suppl 4: S19-S22.

  3. Nazari M, Sekawi Z, Sadeghifard N, Raftari M, Ghafourian S. Methicillin-resistant Staphylococcus aureus. Rev Med Microbiol. 2015; 26 (1): 1-7.

  4. Fux CA, Uehlinger D, Bodmer T, Droz S, Zellweger C, Mühlemann K. Dynamic of hemodialisis catheter colonization y coagulase-negative staphylococci. Infect Control Hosp Epidemiol. 2005; 26 (6): 567-574.

  5. Gómez-González MC, Campos R, Pascua J, Marigliano N, Lancho JM, Teno P. Manejo de la colonización por Staphylococcus aureus meticilin resistente, en pacientes y profesionales de una unidad de hemodiálisis, en una situación de elevada endemia: ¿objetivo cero? Enferm Infecc Microbiol Clin. 2012; 30 (3):124-130.

  6. Lowy FD. How Staphylococcus aureus adapts to its host. N Engl J Med. 2011; 364 (21): 1987-1990.

  7. Fowler VG Jr., Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003; 163 (17): 2066-2072.

  8. Thomer L, Schneewind O, Missiakas D. Pathogenesis of Staphylococcus aureus Bloodstream Infections. Annu Rev Pathol. 2016; 11: 343-364.

  9. Corey GR. Staphylococcus aureus bloodstream infections: definitions and treatment. Clin Infect Dis. 2009; 48 (Suppl 4): S254-S259.

  10. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015; 28 (3): 603-661.

  11. Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia. JAMA. 2014; 312 (13): 1330-1341.

  12. Nissen J, Skov R, Knudsen JD, Østergaard C, Schønheyder H, Frimodt-Møller N et al. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis. J Antimicrob Chemother. 2013; 68 (8): 1894-1900.

  13. Youngster I, Shenoy ES, Hooper DC, Nelson SB. Comparative Evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Clin Infect Dis. 2014; 59 (3): 369-375.

  14. Chang F, Peacock J, Musher D, Triplett P, MacDonald B, Mylotte J et al. Staphylococcus aureus bacteremia. Medicine (Baltimore). 2003; 82 (5): 333-339.

  15. Thwaites G, Scarborough M, Szubert A, Nsutebu E, Tilley R, Greig J et al. Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2018; 391 (10121): 668-678.

  16. Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP et al. Initial low‐dose gentamicin forStaphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis. 2009; 48 (6): 713-721.

  17. Bartash R, Nori P. Beta-lactam combination therapy for the treatment of Staphylococcus aureus and Enterococcus species bacteremia: a summary and appraisal of the evidence. Int J Infect Dis. 2017; 63: 7-12.




2020     |     www.medigraphic.com